Appeal No. 95-2851
Application 08/012,379
Hutchinson et al. (Hutchinson) 4,748,181 May 31, 1988
Abood (Abood ‘162) 4,835,162 May 30, 1989
Bannon et al. (Bannon) 4,946,853 Aug. 7, 1990
Abood (Abood ‘916) 4,966,916 Oct. 30, 1990
Joseph F. Borzelleca et al., “Studies on the Respiratory and Cardiovascular Effects of
(-)-Cotinine”, 137 J. Pharm. Exper. Therapeutics, 313-18 (1962) (Borzelleca).
References relied upon by the board
Keenan (Keenan ‘774) 5,573,774 Nov. 12, 1996
Keenan et al. (Keenan ‘007) 5,596,007 Jan. 21, 1997
THE REJECTION
Claims 1, 2, 4-6, 8-13, 15-17, 19-24, 26-28, 30-33, 67, 68 and 70-99 stand
rejected under 35 U.S.C. § 103 as being unpatentable over Abood ‘916, Abood ‘162,
Bannon, Hutchinson, Borzelleca and appellant’s admissions on pages 4-7 of the
specification.2
OPINION
We have carefully considered all of the arguments advanced by appellant and
the examiner and agree with appellant that the aforementioned rejection is not well
founded. Accordingly, this rejection will be reversed. We will introduce new grounds of
rejection of claims 1, 2, 4-6, 8-13, 15-17, 19-24, 26-28, 30-33, 67, 68 and 70-74 and
91-99 under the provisions of 37 CFR § 1.196(b).
The examiner argues that the Abood references, Bannon and Hutchinson teach
2Abood ‘916 is a division of Abood ‘162.
3
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007